These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 14621103)

  • 21. Oxidative stress in COPD.
    Kirkham PA; Barnes PJ
    Chest; 2013 Jul; 144(1):266-273. PubMed ID: 23880677
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oxidants and COPD.
    MacNee W
    Curr Drug Targets Inflamm Allergy; 2005 Dec; 4(6):627-41. PubMed ID: 17305519
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oxidative stress and antioxidant enzyme activity in South Indian male smokers with chronic obstructive pulmonary disease.
    Arja C; Surapaneni KM; Raya P; Adimoolam C; Balisetty B; Kanala KR
    Respirology; 2013 Oct; 18(7):1069-75. PubMed ID: 23683270
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oxidative stress in patients with COPD.
    Loukides S; Bakakos P; Kostikas K
    Curr Drug Targets; 2011 Apr; 12(4):469-77. PubMed ID: 21194408
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 4-Hydroxy-2-nonenal, a specific lipid peroxidation product, is elevated in lungs of patients with chronic obstructive pulmonary disease.
    Rahman I; van Schadewijk AA; Crowther AJ; Hiemstra PS; Stolk J; MacNee W; De Boer WI
    Am J Respir Crit Care Med; 2002 Aug; 166(4):490-5. PubMed ID: 12186826
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Production of reactive persulfide species in chronic obstructive pulmonary disease.
    Numakura T; Sugiura H; Akaike T; Ida T; Fujii S; Koarai A; Yamada M; Onodera K; Hashimoto Y; Tanaka R; Sato K; Shishikura Y; Hirano T; Yanagisawa S; Fujino N; Okazaki T; Tamada T; Hoshikawa Y; Okada Y; Ichinose M
    Thorax; 2017 Dec; 72(12):1074-1083. PubMed ID: 28724639
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Does oxidative stress alter quadriceps endurance in chronic obstructive pulmonary disease?
    Koechlin C; Couillard A; Simar D; Cristol JP; Bellet H; Hayot M; Prefaut C
    Am J Respir Crit Care Med; 2004 May; 169(9):1022-7. PubMed ID: 15001462
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of Oxidative Stress and Antioxidant Status in Chronic Obstructive Pulmonary Disease.
    Singh S; Verma SK; Kumar S; Ahmad MK; Nischal A; Singh SK; Dixit RK
    Scand J Immunol; 2017 Feb; 85(2):130-137. PubMed ID: 28256060
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exercise-induced quadriceps oxidative stress and peripheral muscle dysfunction in patients with chronic obstructive pulmonary disease.
    Couillard A; Maltais F; Saey D; Debigaré R; Michaud A; Koechlin C; LeBlanc P; Préfaut C
    Am J Respir Crit Care Med; 2003 Jun; 167(12):1664-9. PubMed ID: 12672647
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting oxidant-dependent mechanisms for the treatment of COPD and its comorbidities.
    Bernardo I; Bozinovski S; Vlahos R
    Pharmacol Ther; 2015 Nov; 155():60-79. PubMed ID: 26297673
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Update in chronic obstructive pulmonary disease: role of antioxidant and metabolizing gene polymorphisms.
    Lakhdar R; Denden S; Kassab A; Leban N; Knani J; Lefranc G; Miled A; Chibani JB; Khelil AH
    Exp Lung Res; 2011 Aug; 37(6):364-75. PubMed ID: 21721950
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The importance of exhaled air condensate in assessing the oxidant-antioxidant system in patients with chronic obstructive pulmonary disease.
    Makarevich AE; Ivashkevich DL
    Wiad Lek; 2003; 56(1-2):19-23. PubMed ID: 12901263
    [TBL] [Abstract][Full Text] [Related]  

  • 33. COPD: balancing oxidants and antioxidants.
    Fischer BM; Voynow JA; Ghio AJ
    Int J Chron Obstruct Pulmon Dis; 2015; 10():261-76. PubMed ID: 25673984
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antioxidant therapeutic targets in COPD.
    Rahman I; Kilty I
    Curr Drug Targets; 2006 Jun; 7(6):707-20. PubMed ID: 16787173
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rehabilitation decreases exercise-induced oxidative stress in chronic obstructive pulmonary disease.
    Mercken EM; Hageman GJ; Schols AM; Akkermans MA; Bast A; Wouters EF
    Am J Respir Crit Care Med; 2005 Oct; 172(8):994-1001. PubMed ID: 16040783
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New frontiers in the treatment of comorbid cardiovascular disease in chronic obstructive pulmonary disease.
    Brassington K; Selemidis S; Bozinovski S; Vlahos R
    Clin Sci (Lond); 2019 Apr; 133(7):885-904. PubMed ID: 30979844
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Failed upregulation of TFAM protein and mitochondrial DNA in oxidatively deficient fibers of chronic obstructive pulmonary disease locomotor muscle.
    Konokhova Y; Spendiff S; Jagoe RT; Aare S; Kapchinsky S; MacMillan NJ; Rozakis P; Picard M; Aubertin-Leheudre M; Pion CH; Bourbeau J; Hepple RT; Taivassalo T
    Skelet Muscle; 2016; 6():10. PubMed ID: 26893822
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Systemic poly(ADP-ribose) polymerase-1 activation, chronic inflammation, and oxidative stress in COPD patients.
    Hageman GJ; Larik I; Pennings HJ; Haenen GR; Wouters EF; Bast A
    Free Radic Biol Med; 2003 Jul; 35(2):140-8. PubMed ID: 12853070
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Six-minute walking-induced systemic inflammation and oxidative stress in muscle-wasted COPD patients.
    van Helvoort HA; Heijdra YF; de Boer RC; Swinkels A; Thijs HM; Dekhuijzen PN
    Chest; 2007 Feb; 131(2):439-45. PubMed ID: 17296645
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NRF2 targeting: a promising therapeutic strategy in chronic obstructive pulmonary disease.
    Boutten A; Goven D; Artaud-Macari E; Boczkowski J; Bonay M
    Trends Mol Med; 2011 Jul; 17(7):363-71. PubMed ID: 21459041
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.